Vassilios Lougaris

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome”.

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood(2022)10.1182/blood.2022018546

N/A

3.2DataRank · unranked

132 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +17 more

Interim analysis: Open-label extension study of leniolisib for patients with APDS

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.09.032

N/A

1.2DataRank · unranked

40 citations

Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +15 more

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

EMBO Molecular Medicine(2021)10.15252/emmm.202013545

N/A

0.593DataRank · unranked

51 citations

E. Mercuri, Genni Enza Marcovecchio, Maria Carmina Castiello, Giulia Schiroli, Luisa Albano +18 more

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clinical Immunology(2024)10.1016/j.clim.2024.110400

N/A

0.434DataRank · unranked

17 citations

Anna Šedivá, Virgil A. S. H. Dalm, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +14 more

Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.08.020

N/A

0.385DataRank · unranked

12 citations

Daniele Canarutto, Simona Porcellini, Francesca Sanvito, Francesca Cecere, Valentina Vavassori +15 more

Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T‐cells for the treatment of Hyper IgM1

The EMBO Journal(2023)10.15252/embj.2023114188

N/A

0DataRank · unranked

10 citations

Claudia Asperti, Valentina Vavassori, Simona Porcellini, Elisabetta Rovelli, Marianna Paulis +14 more

Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-kB pathway

HAL (Le Centre pour la Communication Scientifique Directe)(2023)10.22541/au.167330741.18394805/v1

N/A

0DataRank · unranked

2 citations

Adrian Gervais, Jérémie Rosain, Audrey Parent, Axel Cederholm, Darawan Rinchai +95 more

Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents

Journal of Clinical Investigation(2021)10.1172/jci150143

N/A

0DataRank · unranked

37 citations

David Langlais, Vivien Béziat, Franck Rapaport, Geetha Rao, Tomi Lazarov +42 more

Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study

Future Rare Diseases(2024)10.1080/23995270.2024.2379239

N/A

0DataRank · unranked

0 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon +6 more